Document is current
Any future updates will be listed below
-
Authors
Bollas, Audrey E.
Rajkovic, Andrei
Ceyhan, Defne
Gaither, Jeffrey B.
Mardis, Elaine R.
White, Peter
- License Information
-
More Information
Article History
Received: 8 July 2023
Accepted: 13 February 2024
First Online: 20 February 2024
Declarations
:
: This study was reviewed and approved by the Institutional Review Board (IRB) of The Abigail Wexner Research Institute at Nationwide Children's Hospital (Office for Human Research Protections (OHRP) IORG0000326; IRB00000568) as IRB17-00206 (“Institute for Genomic Medicine Comprehensive Profiling for Cancer, Blood, and Somatic Disorders”). The participant’s legal guardian/next of kin provided written informed consent to participate in this study.
: Not applicable.
: No competing interests: AEB, AR, DC, JBG, and PW. ERM: Qiagen N.V., supervisory board member, honorarium, and stock-based compensation. Singular Genomics Systems, Inc., board of directors, honorarium, and stock-based compensation.
